Get startedLog in
    Picture of Medexus Pharmaceuticals logo

    MDP — Medexus Pharmaceuticals News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapSuper Stock
    All News

    Brief: Medexus Pharma Enters Into Exclusive License To Register, Commercialize Triamcinolone Hexacetonide In U.S With Ethypharm

    Picture of Medexus Pharmaceuticals logoMedexus Pharmaceuticals
    18/12/2020 13:39
    Dec 18 (Reuters) - Medexus Pharmaceuticals Inc  MDP.V :
    * MEDEXUS PHARMACEUTICALS INC -  ENTERED INTO EXCLUSIVE
LICENSE TO
REGISTER AND COMMERCIALIZE TRIAMCINOLONE HEXACETONIDE IN U.S
WITH ETHYPHARM

Source text for Eikon:  ID:nGNX7C269l 
Further company coverage:  MDP.V 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Medexus Pharmaceuticals

    See all news